Meanwhile, Almac has added a second high-throughput peptide line at its Edinburgh, Scotland, facility, where it manufactures neoantigen-derived peptides for use in patient-specific cancer vaccines.

Almac Group, a contract development and manufacturing organization, announced on Jan. 2, 2019 that it has brought a second stream of high-throughput good manufacturing practice (GMP) peptide ...

Almac Sciences (Scotland) Ltd is part of the global Almac Group. The second licence was signed with Edinburgh Instruments, which is globally recognised for the development and manufacture of high-tech ...

Dow plans deep cuts amid poor economy Almac Group will relocate its custom peptide synthesis operation from Elvingston, Scotland, to a newly built wing of the Edinburgh Technopole. The move ...

Two of Almac’s main research projects have been ... of a podium presentation by Dr Charlie Gourley of the University of Edinburgh Cancer Research UK Centre, where the patients were treated.

while the Edinburgh Technopole science park is already home to the likes of AMD, BioBest, Roslin CT, Cambrex and Almac. Edinburgh Technopole is a 126-acre life sciences campus comprising ten ...

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery ...

The new role will help support Almac’s commitment to net zero energy by 2045 and cut the Group’s Scope one and Scope two emissions in half by 2030. Raja will work […] Skip to content ...

Almac pharmaceutical firm is to spend £80m on two new manufacturing facilities in Craigavon, County Armagh. They are the latest stage of an expansion plan which was announced at the end of 2021.